Nuix’s Shift to Larger Deals Extends Procurement Cycles, Defers Revenue

Nuix Limited reported an 8% rise in Annualised Contract Value for FY25, driven by a remarkable 132% growth in its Nuix Neo platform. Despite flat revenue, the company achieved a 24.5% increase in Cash EBITDA and outlined a confident outlook for FY26.

  • Annualised Contract Value (ACV) up 8% to $228.4 million
  • Nuix Neo ACV soars 132%, reaching $28.1 million
  • Cash EBITDA rises 24.5% to $37.2 million with margin expansion
  • Revenue flat at $221.5 million, impacted by fewer multi-year deals
  • Technology restructure completed; strong FY26 growth outlook
An image related to Nuix Limited
Image source middle. ©

Strong Subscription Base and Nuix Neo Drive Growth

Nuix Limited’s FY25 financial results reveal a company in transition, capitalising on its intelligent software platform to deepen customer engagement and expand its footprint. The headline figure; an 8% increase in Annualised Contract Value (ACV) to $228.4 million; underscores steady demand, with subscription licences comprising 97% of this total, reflecting a highly recurring revenue model.

Central to this growth story is Nuix Neo, the company’s AI-enriched platform, which saw its ACV skyrocket by 132% to $28.1 million. This leap was driven by both new customer acquisitions and upselling to existing clients, particularly in financial services, law enforcement, and regulatory sectors. Nuix Neo’s scalable, automated, and AI-powered capabilities appear to be resonating strongly with larger enterprise customers, aligning with Nuix’s strategic pivot towards higher-value contracts.

Financial Performance Highlights and Operational Discipline

While revenue remained essentially flat at $221.5 million, this was influenced by a decline in multi-year deals, which fell to 27% of revenue from 31% the previous year. The company’s focus on larger, more complex contracts has extended procurement cycles, delaying some deal closures into FY26. Despite this, Nuix delivered a robust 24.5% increase in Cash EBITDA to $37.2 million, with margins expanding to 16.8%, reflecting disciplined cost management and lower variable pay expenses.

Research and Development (R&D) spend rose modestly by 3.5% to $54.8 million, with a notable shift from capitalised to expensed R&D, indicative of evolving workflows as Nuix Neo capabilities mature. The company also completed a significant technology organisational restructure, consolidating core technology hubs across Sydney, Washington DC, Pittsburgh, London, and Hyderabad, aiming to enhance operational efficiency and speed of execution without increasing operating costs.

Geographic and Customer Segmentation Insights

Nuix’s global reach remains a strength, with North America accounting for 54% of ACV, followed by EMEA at 25% and Asia Pacific at 21%. All regions reported ACV growth around 7.5% to 8.4%, driven by sector-specific wins in technology, advisory, financial services, and government agencies. The customer base is well diversified and long-tenured, with 97% subscription ACV and over 80% of ACV generated outside Australia, mitigating concentration risk.

Outlook and Strategic Priorities for FY26

Looking ahead, Nuix is targeting continued ACV growth led by Nuix Neo, with revenue growth expected to outpace operating cost increases. The company anticipates maintaining positive underlying cash flow for the full year. Key strategic priorities include further development of Nuix Neo capabilities and a continued focus on securing higher-value contracts, including several large deals deferred from FY25. Nuix Neo Foundation, a pathway product easing customer transition to the full AI-enabled platform, is also positioned to reduce friction in sales cycles.

Overall, Nuix’s FY25 results reflect a company successfully navigating the complexities of evolving enterprise software markets, balancing innovation investment with operational discipline, and positioning itself for scalable growth in a competitive landscape.

Bottom Line?

Nuix’s FY25 results set the stage for accelerated Nuix Neo adoption and higher-value contract wins in FY26, but timing shifts in large deals warrant close investor attention.

Questions in the middle?

  • How will the lengthening procurement cycles for large contracts impact Nuix’s revenue visibility in FY26?
  • What is the potential market impact and scalability of Nuix Neo Foundation in converting smaller customers?
  • How will ongoing legal costs and restructuring expenses influence statutory earnings going forward?